Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hesse

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectivesRoland Baron, Eric Hesse
Current Osteoporosis Reports|March 25, 2019
MicroRNAs in Bone MetastasisEric Hesse, Hanna Taipaleenmäki
Current Osteoporosis Reports|August 22, 2022
Muscle and Bone Defects in Metastatic DiseaseMartina Pauk, Hiroaki Saito, Eric Hesse, et al.
British Journal of Pharmacology|August 20, 2019
Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevanceMargherita Puppo, Hanna Taipaleenmäki, Eric Hesse, et al.
Thyroid : Official Journal of the American Thyroid Association|May 18, 2010
Oncofetal fibronectin mRNA is highly abundant in the blood of patients with papillary thyroid carcinoma and correlates with high-serum thyroid-stimulating hormone levelsMichael Wehmeier, Thorsten Petrich, Korbinian Brand, et al.
Elife|April 25, 2024
Tgif1-deficiency impairs cytoskeletal architecture in osteoblasts by activating PAK3 signalingSimona Bolamperti, Hiroaki Saito, Sarah Heerdmann, et al.
Zeitschrift Fur Rheumatologie|January 13, 2025
[Influencing fracture healing by specific osteoporosis medications]Ulla Stumpf, Ralf Schmidmaier, Hanna Taipaleenmäki, et al.
Der Unfallchirurg|May 25, 2019
[Influence of specific osteoporosis drugs on fracture healing]Eric Hesse, Carl Neuerburg, Christian Kammerlander, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 14, 2025
Tgif1-deficiency impairs osteoclast differentiation through PP2A-mediated ERK1/2 dephosphorylation and attenuates bone loss in miceMiki Maeda, Hiroaki Saito, Amy B P Ribet, et al.
Der Unfallchirurg|August 16, 2019
[Establishment of fracture liaison services in Germany]Eric Hesse, Wolfgang Böcker, Christian Kammerlander, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectivesRoland Baron, Eric Hesse
Current Osteoporosis Reports|March 25, 2019
MicroRNAs in Bone MetastasisEric Hesse, Hanna Taipaleenmäki
Current Osteoporosis Reports|August 22, 2022
Muscle and Bone Defects in Metastatic DiseaseMartina Pauk, Hiroaki Saito, Eric Hesse, et al.
British Journal of Pharmacology|August 20, 2019
Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevanceMargherita Puppo, Hanna Taipaleenmäki, Eric Hesse, et al.
Thyroid : Official Journal of the American Thyroid Association|May 18, 2010
Oncofetal fibronectin mRNA is highly abundant in the blood of patients with papillary thyroid carcinoma and correlates with high-serum thyroid-stimulating hormone levelsMichael Wehmeier, Thorsten Petrich, Korbinian Brand, et al.
Elife|April 25, 2024
Tgif1-deficiency impairs cytoskeletal architecture in osteoblasts by activating PAK3 signalingSimona Bolamperti, Hiroaki Saito, Sarah Heerdmann, et al.
Zeitschrift Fur Rheumatologie|January 13, 2025
[Influencing fracture healing by specific osteoporosis medications]Ulla Stumpf, Ralf Schmidmaier, Hanna Taipaleenmäki, et al.
Der Unfallchirurg|May 25, 2019
[Influence of specific osteoporosis drugs on fracture healing]Eric Hesse, Carl Neuerburg, Christian Kammerlander, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 14, 2025
Tgif1-deficiency impairs osteoclast differentiation through PP2A-mediated ERK1/2 dephosphorylation and attenuates bone loss in miceMiki Maeda, Hiroaki Saito, Amy B P Ribet, et al.
Der Unfallchirurg|August 16, 2019
[Establishment of fracture liaison services in Germany]Eric Hesse, Wolfgang Böcker, Christian Kammerlander, et al.
Pageof 6